Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...